ANTI-CD3 EPSILON-ANTIKÖRPER
European patent · EP3634998 · In force
Register entry
- Publication number
- EP3634998
- Application number
- EP18729644
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 4, 2018
- Published
- Apr 15, 2020
- Granted
- Feb 26, 2025
- Protection ends at the latest
- Jun 3, 2038
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C07K 16/18 (2006.01)C07K 16/24 (2006.01)C07K 16/28 (2006.01)C07K 16/32 (2006.01)
- Priority
- US 201762515293 P 05.06.2017EP 17203832 27.11.2017
- PCT application
- PCT/EP2018/064630 04.06.2018
- PCT publication
- WO2018/224441 13.12.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Jan 7, 2026
Change
Published in Swissreg on 07.01.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- Mar 12, 2025
Owner
- Owner
- Numab Therapeutics AG, Einsiedlerstrasse 34, 8820 Wädenswil → Numab Therapeutics AG, Bachtobelstrasse 5, 8810 Horgen
Published in Swissreg on 12.03.2025
- Mar 12, 2025
Change
Published in Swissreg on 12.03.2025
- Feb 26, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 26.02.2025
Parties
Inventor
GUNDE, Tea
8005 Zurich
HESS, Christian
8045 Zurich
MEYER, Sebastian
5445 Eggenwil
SIMONIN, Alexandre
68128 Rosenau, FR
BELTRAMETTI, Teddy
6467 Schattdorf
URECH, David
8645 Jona
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.